Thursday, August 21, 2025 1:00 PM Eastern Time / 10:00 AM Pacific Time
Presenter: Dr. Chris Heery, Chief Medical Officer, Arcellx
Join us to learn about anito-cel, a novel BCMA-targeted DNA CAR T-cell therapy that is being developed by Arcellx for generalized myasthenia gravis (gMG). Dr. Chris Heery, Chief Medical Officer at Arcellx, will explain how CAR T-cell therapy works and introduce the clinical trial of anito-cel in gMG.
This webinar is sponsored by Arcellx.